Search for Clinical Trial Results
Acute Monoblastic Leukemia - 182 Studies Found
Status | Study |
Completed |
Study Name: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia Condition:
|
Active, not recruiting |
Study Name: MEK Inhibitor MEK162, Idarubicin, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS Condition:
|
Terminated |
Study Name: Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy Condition:
|
Completed |
Study Name: Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: AML Therapy With Irradiated Allogeneic Cells Condition:
|